According to the company and its U.S. distributor AIDP, the new 1% version provides formulating, storage, and cost-in-use advantages.
Photo © Shutterstock.com/photographyfirm
Vitamin K2 supplier Kappa Bioscience AS (Oslo, Norway) has introduced a new 1% high-concentrate version of its K2Vital Delta ingredient. The K2Vital Delta line comprises microencapsulated vitamin K2 MK-7.
Says the company in a press release: “Microencapsulation protection is critical for vitamin K2 when it is formulated with minerals such as calcium or magnesium. In 2012, Kappa Bioscience discovered that K2 degrades in the presence of minerals, and many K2 consumer products were not shelf-stable. With the help of BASF’s beadlet technology, Kappa launched microencapsulated K2Vital Delta in a 0.2% format in 2013. Delta has gained wide acceptance in a range of dosage forms and global sales are estimated to be at approximately 12% of the K2 market.”
According to the company and its U.S. distributor AIDP (City of Industry, CA), the new 1% version provides formulating, storage, and cost-in-use advantages.
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.